Staphylococcal enterotoxins: A purging experience in review, part I

Clinical Microbiology Newsletter

Volumn 27, Issue 23, 2005, Pages 179-186

  Stiles, Bradley G ^a   Krakauer, Teresa ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BOTULINUM TOXIN; CYTOKINE; HLA ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; NEUROTOXIN; STAPHYLOCOCCUS ENTEROTOXIN; SUPERANTIGEN; TOXIC SHOCK SYNDROME TOXIN 1; VIRULENCE FACTOR;

AMINO ACID SEQUENCE; ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; BINDING AFFINITY; CELL PROLIFERATION; CLOSTRIDIUM BOTULINUM; CYTOKINE PRODUCTION; FEVER; FOOD POISONING; GRAM POSITIVE BACTERIUM; HISTOCOMPATIBILITY; HUMAN; HYPOTENSION; IN VITRO STUDY; IN VIVO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PATHOGENESIS; PROTEIN PROTEIN INTERACTION; REVIEW; SHOCK; SIGNAL TRANSDUCTION; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE; TOXIC SHOCK SYNDROME;

EID: 27844495650     PISSN: 01964399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinmicnews.2005.11.001     Document Type: Article

References (133)

1. Kotzin B.L. Superantigens and their potential role in human disease Adv. Immunol. 54 1993 99 166
2. Monday S.R., Bohach G.A. Properties of Staphylococcus aureus enterotoxins and toxic shock syndrome toxin-1 Alouf J.E. Freer J.H. The Comprehensive sourcebook of bacterial protein toxins 1999 Academic Press London 589 610
3. Schuberth H-J. Characterization of leukocytotoxic and superantigen-like factors produced by Staphylococcus aureus isolates from milk of cows with mastitis Vet. Microbiol. 82 2000 187 199
4. Fleischer B. An evolutionary conserved mechanism of T-cell activation by microbial toxins. Evidence for different affinities of T-cell receptor-toxin interaction J. Immunol. 146 1991 11 17
5. Smith B.G. and H. Johnson The effect of staphylococcal enterotoxins on the primary in vitro immune response J. Immunol. 115 1975 575 578
6. Poindexter N.J., Schlievert P.M. Toxic-shock-syndrome toxin 1-induced proliferation of lymphocytes: comparison of the mitogenic response of human, murine, and rabbit lymphocytes J. Infect. Dis. 153 1986 772 779
7. Bhakdi S. Correlation between toxin binding and hemolytic activity in membrane damage by staphylococcal alpha-toxin Infect. Immun. 46 1984 318 323
8. Foster T.J. The Staphylococcus aureus "superbug." J. Clin. Investig. 114 2004 1693 1696
9. Kreiswirth B. Evidence for a clonal origin of methicillin resistance in Staphylococcus aureus Science 259 1993 227 230
10. Centers for Disease Control and Prevention Reduced susceptibility of Staphylococcus aureus to vancomycin - Japan 1996 Morb. Mortal. Wkly. Rep. 46 1997 624 626
11. Tenover F.C., McDonald L.C. Vancomycin-resistant staphylococci and enterococci: epidemiology and control Curr. Opin. Infect. Dis. 18 2005 300 305
12. Kim T. The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals Infect. Cont. Hosp. Epidemiol. 22 2001 99 104
13. Vriens M. Costs associated with a strict policy to eradicate methicillin-resistant Staphylococcus aureus in a Dutch university medical center: a 10-year survey Eur. J. Clin. Microbiol. Infect. Dis. 21 2002 782 786
14. Carmeli Y. Health and economic outcomes of vancomycin-resistant enterococci Arch. Intern. Med. 162 2002 2223 2228
15. Capitano B. Cost effect of managing methicillin-resistant Staphylococcus aureus in a long-term care facility J. Am. Geriatr. Soc. 51 2003 10 16
16. Dinges M.M. Exotoxins of Staphylococcus aureus Clin. Microbiol. Rev. 13 2000 16 34
17. Wieneke A.A. Staphylococcal food poisoning in the United Kingdom, 1969-1990 Epidemiol. Infect. 110 1993 519 531
18. Bergdoll M.S. Monkey feeding test for staphylococcal enterotoxin Methods Enzymol. 165 1988 324 333
19. Le Loir Y. Staphylococcus aureus and food poisoning Genet. Mol. Res. 2 2003 63 76
20. McGann V.G. Evaluation of resistance to staphylococcal enterotoxin B: naturally acquired antibodies of man and monkey J. Infect. Dis. 124 1971 206 213
21. Holmberg S.D., Blake P.A. Staphylococcal food poisoning in the United States. New facts and old misconceptions JAMA 251 1984 487 489
22. Jett M. Staphylococcus aureus enterotoxin B challenge of monkeys: correlation of plasma levels of arachidonic acid cascade products with occurrence of illness Infect. Immun. 58 1990 3494 3499
23. Scheuber P.H. Cysteinyl leukotrienes as mediators of staphylococcal enterotoxin B in the monkey Eur. J. Clin. Investig. 17 1987 455 459
24. Alber G. Role of substance P in immediate-type skin reactions induced by staphylococcal enterotoxin B in unsensitized monkeys J. Allergy. Clin. Immunol. 84 1989 880 885
25. Tiegs G. Requirement of peptidergic sensory innervation for disease activity in murine models of immune hepatitis and protection by beta-adrenergic stimulation J. Neuroimmunol 96 1999 131 143
26. Wang X. Fos expression in the rat brain after intraperitoneal injection of Staphylococcus enterotoxin B and the effect of vagotomy Neurochem. Res. 29 2004 1667 1674
27. Rolfe V.E., Levin R.J. Vagotomy inhibits the jejunal fluid secretion activated by luminal ileal Escherichia coli STa in the rat in vivo Gut 44 1999 615 619
28. Goehler L.E. Interleukin-1 beta in immune cells of the abdominal vagus nerve: a link between the immune and nervous systems? J. Neurosci. 19 1999 2799 2806
29. Todd J. Toxic-shock syndrome associated with phage-group-I staphylococci Lancet ii 1978 1116 1118
30. Shands K.N. Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases N. Engl. J. Med. 303 1980 1436 1442
31. Schlievert P.M. Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome J. Infect. Dis. 143 1981 509 516
32. Crass B.A., Bergdoll M.S. Involvement of staphylococcal enterotoxins in nonmenstrual toxic shock syndrome J. Clin. Microbiol. 23 1986 1138 1139
33. McCormick J.K. Toxic shock syndrome and bacterial superantigens: an update Annu. Rev. Microbiol. 55 2001 77 104
34. Mills J. Control of production of toxic-shock-syndrome toxin-1 (TSST-1) by magnesium ions J. Infect. Dis. 151 1985 1158 1161
35. Schlievert P.M. Toxic shock syndrome Staphylococcus aureus: effect of tampons on toxic shock syndrome toxin 1 production Obstet. Gynecol. 64 1984 666 671
36. Bergdoll M.S. A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates Lancet i 1981 1017 1021
37. Reiser R.F. Purification and some physicochemical properties of toxic-shock toxin Biochemistry 22 1983 3907 3912
38. Freedman J.D., Beer D.J. Expanding perspectives on the toxic shock syndrome Adv. Intern. Med. 36 1991 363 397
39. Bohach G.A. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses Crit. Rev. Microbiol. 17 1990 251 272
40. Schlievert P.M. Alteration of immune function by staphylococcal pyrogenic exotoxin type C: possible role in toxic-shock syndrome J. Infect. Dis. 147 1983 391 398
41. Ikejima T. Induction by toxic-shock-syndrome toxin-1 of a circulating tumor necrosis factor-like substance in rabbits and of immunoreactive tumor necrosis factor and interleukin-1 from human mononuclear cells J. Infect. Dis. 158 1988 1017 1025
42. Parsonnet J. Mediators in the pathogenesis of toxic shock syndrome: overview Rev. Infect. Dis. 11 1989 S263 S269
43. Garbe P.L. Staphylococcus aureus isolates from patients with nonmenstrual toxic shock syndrome. Evidence for additional toxins JAMA 253 1985 2538 2542
44. Andrews M.M. Recurrent nonmenstrual toxic shock syndrome: clinical manifestations, diagnosis, and treatment Clin. Infect. Dis. 32 2001 1470 1479
45. Bonventre P.F. Antibody responses to toxic-shock-syndrome (TSS) toxin by patients with TSS and by healthy staphylococcal carriers J. Infect. Dis. 150 1984 662 666
46. Vergeront J.M. Prevalence of serum antibody to staphylococcal enterotoxin F among Wisconsin residents: implications for toxic-shock syndrome J. Infect. Dis. 148 1983 692 698
47. Notermans S. Serum antibodies to enterotoxins produced by Staphylococcus aureus with special reference to enterotoxin F and toxic shock syndrome J. Clin. Microbiol. 18 1983 1055 1060
48. Mahlknecht U. The toxic shock syndrome toxin-1 induces anergy in human T-cells in vivo Hum. Immunol. 45 1996 42 45
49. Hofer M.F. Differential effects of staphylococcal toxic shock syndrome toxin-1 on B cell apoptosis Proc. Natl. Acad. Sci. USA 93 1996 5425 5430
50. Stiles B.G. Biological activity of toxic shock syndrome toxin 1 and a site-directed mutant, H135A, in a lipopolysaccharide-potentiated mouse lethality model Infect. Immun. 63 1995 1229 1234
51. Stiles B.G. Mucosal vaccination with recombinantly attenuated staphylococcal enterotoxin B and protection in a murine model Infect. Immun. 69 2001 2031 2036
52. Nilsson I.M. Protection against Staphylococcus aureus sepsis by vaccination with recombinant staphylococcal enterotoxin A devoid of superantigenicity J. Infect. Dis. 180 1999 1370 1373
53. Bavari S. Superantigen vaccines: a comparative study of genetically attenuated receptor-binding mutants of staphylococcal enterotoxin A J. Infect. Dis. 174 1996 338 345
54. McCormick J.K. Development of streptococcal pyrogenic exotoxin C vaccine toxoids that are protective in the rabbit model of toxic shock syndrome J. Immunol. 165 2000 2306 2312
55. Roggiani M. Toxoids of streptococcal pyrogenic exotoxin A are protective in rabbit models of streptococcal toxic shock syndrome Infect. Immun. 68 2000 5011 5017
56. Gampfer J. Double mutant and formaldehyde inactivated TSST-1 as vaccine candidates for TSST-1-induced toxic shock syndrome Vaccine 20 2002 1354 1364
57. Ulrich R.G. Development of engineered vaccines effective against structurally related bacterial superantigens Vaccine 16 1998 1857 1864
58. Hu D.L. Vaccination with nontoxic mutant toxic shock syndrome toxin-1 protects against Staphylococcus aureus infection J. Infect. Dis. 188 2003 743 752
59. Marrack P. and J. Kappler The staphylococcal enterotoxins and their relatives Science 248 1990 705 711
60. Choi Y. Interaction of Staphylococcus aureus toxin " superantigens" with human T-cells Proc. Natl. Acad. Sci. USA 86 1989 8941 8945
61. Webb S.R., Gascoigne N.R. T-cell activation by superantigens Curr. Opin. Immunol. 6 1994 467 475
62. Blackman M.A., Woodland D.L. In vivo effects of superantigens Life Sci. 57 1995 1717 1735
63. Johnson H.M. Superantigens: structure and relevance to human disease Proc. Soc. Exp. Biol. Med. 212 1996 99 109
64. Florquin S. and L. Aaldering Superantigens: a tool to gain new insight into cellular immunity Res. Immunol. 148 1997 373 386
65. Li H. The structural basis of T-cell activation by superantigens Annu. Rev. Immunol. 17 1999 435 466
66. Ribeiro-Dias F. Mycoplasma arthritidis superantigen (MAM)-induced macrophage nitric oxide release is MHC class II restricted, interferon gamma dependent, and toll-like receptor 4 independent Exp. Cell Res. 286 2003 345 354
67. Ohmen J.D. Evidence for a superantigen in human tuberculosis Immunity 1 1994 35 43
68. Legaard P.K. The superantigen Pseudomonas exotoxin A requires additional functions from accessory cells for T lymphocyte proliferation Cell Immunol. 135 1991 372 382
69. Proft T., Fraser J.D. Bacterial superantigens Clin. Exp. Immunol. 133 2003 299 306
70. Proft T. Superantigens and streptococcal toxic shock syndrome Emerg. Infect. Dis. 9 2003 1211 1218
71. Proft T. Identification and characterization of novel superantigens from Streptococcus pyogenes J. Exp. Med. 189 1999 89 102
72. Stuart P.M. Characterization of human T-cell responses to Yersinia enterocolitica superantigen Hum. Immunol. 43 1995 269 275
73. Abe J. Pathogenic role of a superantigen in Yersinia pseudotuberculosis infection Adv. Exp. Med. Biol. 529 2003 459 461
74. Dobrescu D. Enhanced HIV-1 replication in V beta 12 T-cells due to human cytomegalovirus in monocytes: evidence for a putative herpesvirus superantigen Cell 82 1995 753 763
75. Sutkowski N. An Epstein-Barr virus-associated superantigen J. Exp. Med. 184 1996 971 980
76. Yao Z. Herpesvirus saimiri open reading frame 14, a protein encoded by T lymphotropic herpesvirus, binds to MHC class II molecules and stimulates T-cell proliferation J. Immunol. 156 1996 3260 3266
77. Torres B.A. Characterization of Nef-induced CD4 T-cell proliferation Biochem. Biophys. Res. Commun. 225 1996 54 61
78. Acha-Orbea H., MacDonald H.R. Superantigens of mouse mammary tumor virus Annu. Rev. Immunol. 13 1995 459 486
79. Lafon M. Rabies virus superantigen Res. Immunol. 144 1993 209 213
80. Betley M.J. Staphylococcal enterotoxin A gene is associated with a variable genetic element Proc. Natl. Acad. Sci. USA 81 1984 5179 5183
81. Betley M.J. Staphylococcal enterotoxins, toxic shock syndrome toxin and streptococcal pyrogenic exotoxins: a comparative study of their molecular biology Chem. Immunol. 55 1992 1 35
82. Singh B.R. Crystal and solution structures of superantigenic staphylococcal enterotoxins compared Struct. Biol. 1 1994 358 360
83. Swaminathan S. Crystal structure of staphylococcal enterotoxin B, a superantigen Nature 359 1992 801 806
84. Papageorgiou A.C. Crystal structure of microbial superantigen staphylococcal enterotoxin B at 1.5 angstrom resolution: implications for superantigen recognition by MHC class II molecules and T-cell receptors J. Mol. Biol. 277 1998 61 79
85. Papageorgiou A.C. The refined crystal structure of toxic shock syndrome toxin-1 at 2.7 angstrom resolution J. Mol. Biol. 260 1996 553 569
86. Hurley J.M. Identification of class II major histocompatibility complex and T-cell receptor binding sites in the superantigen toxic shock syndrome toxin 1 J. Exp. Med. 181 1995 2229 2235
87. Kappler J.W. Mutations defining functional regions of the superantigen staphylococcal enterotoxin B J. Exp. Med. 175 1992 387 396
88. Kum W.W., Chow A.W. Inhibition of staphylococcal enterotoxin A-induced superantigenic and lethal activities by a monoclonal antibody to toxic shock syndrome toxin-1 J. Infect. Dis. 183 2001 1739 1748
89. Bavari S. Cross-reactive antibodies prevent the lethal effects of Staphylococcus aureus superantigens J. Infect. Dis. 180 1999 1365 1369
90. Thompson N.E. Monoclonal antibodies to staphylococcal enterotoxin B and C: cross-reactivity and localization of epitopes on tryptic fragments Infect. Immun. 45 1984 281 285
91. Spero L. On the cross-reactivity of staphylococcal enterotoxins A, B, and C J. Immunol. 120 1978 86 89
92. Bohach G.A. Cross-neutralization of staphylococcal and streptococcal pyrogenic toxins by monoclonal and polyclonal antibodies Infect. Immun. 56 1988 400 404
93. Mollick J.A. Staphylococcal exotoxin activation of T-cells. Role of exotoxin-MHC class II binding affinity and class II isotype J. Immunol. 146 1991 463 468
94. Yagi J. Control of T-cell responses to staphylococcal enterotoxins by stimulator cell MHC class II polymorphism J. Immunol. 147 1991 1398 1405
95. Herrmann T. Different staphylococcal enterotoxins bind preferentially to distinct major histocompatibility complex class II isotypes Eur. J. Immunol. 19 1989 2171 2174
96. Herman A. HLA-DR alleles differ in their ability to present staphylococcal enterotoxins to T-cells J. Exp. Med. 172 1990 709 717
97. Chintagumpala M.M. Staphylococcal toxins bind to different sites on HLA-DR J. Immunol. 147 1991 3876 3881
98. See R.H. Receptors for toxic shock syndrome toxin-1 and staphylococcal enterotoxin A on human blood monocytes Can. J. Microbiol. 38 1992 937 944
99. Hudson K.R. Staphylococcal enterotoxin A has two cooperative binding sites on major histocompatibility complex class II J. Exp. Med. 182 1995 711 720
100. Tiedemann R.E., Fraser J.D. Cross-linking of MHC class II molecules by staphylococcal enterotoxin A is essential for antigen-presenting cell and T-cell activation J. Immunol. 157 1996 3958 3966
101. Thibodeau J. Molecular characterization and role in T-cell activation of staphylococcal enterotoxin A binding to the HLA-DR alpha-chain J. Immunol. 158 1997 3698 3704
102. Ulrich R.G. Staphylococcal enterotoxins A and B share a common structural motif for binding class II major histocompatibility complex molecules Nat. Struct. Biol. 2 1995 554 560
103. Mehindate K. Cross-linking of major histocompatibility complex class II molecules by staphylococcal enterotoxin A superantigen is a requirement for inflammatory cytokine gene expression J. Exp. Med. 182 1995 1573 1577
104. Jardetzky T.S. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen Nature 368 1994 711 718
105. Kim J. Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1 Science 266 1994 1870 1874
106. Kum W.W. A mutation at glycine residue 31 of toxic shock syndrome toxin-1 defines a functional site critical for major histocompatiblity complex class II binding and superantigenic activity J. Infect. Dis. 174 1996 1261 1270
107. Kappler J. V beta-specific stimulation of human T-cells by staphylococcal toxins Science 244 1989 811 813
108. Choi Y. Selective expansion of T-cells expressing V beta 2 in toxic shock syndrome J. Exp. Med. 172 1990 981 984
109. Newton D.W. Mutations in the MHC class II binding domains of staphylococcal enterotoxin A differentially affect T-cell receptor Vβ specificity J. Immunol. 157 1996 3988 3994
110. Leder L. A mutational analysis of the binding of staphylococcal enterotoxins B and C3 to the T-cell receptor beta chain and major histocompatiblity complex class II J. Exp. Med. 187 1998 823 833
111. Gascoigne N.R., Ames K.T. Direct binding of secreted T-cell receptor beta chain to superantigen associated with class II major histocompatiblity complex protein Proc. Natl. Acad. Sci. USA 88 1991 613 616
112. Fields B.A. Crystal structure of a T-cell receptor beta-chain complexed with a superantigen Nature 384 1996 188 192
113. Li H. Three-dimensional structure of the complex between a T-cell receptor beta chain and the superantigen staphylococcal enterotoxin B Immunity 9 1998 807 816
114. Seth A. Binary and ternary complexes between T-cell receptor, class II MHC and superantigen in vitro Nature 369 1994 324 327
115. Redpath S. Cutting edge: trimolecular interaction of TCR with MHC class II and bacterial superantigen shows a similar affinity to MHC: peptide ligands J. Immunol. 163 1999 6 10
116. Bonventre P.F. A mutation at histidine residue 135 of toxic shock syndrome toxin yields an immunogenic protein with minimal toxicity Infect. Immun. 63 1995 509 515
117. Drynda A. Role of a carboxy-terminal site of toxic shock syndrome toxin 1 in eliciting immune responses of human peripheral blood mononuclear cells Infect. Immun. 63 1995 1095 1101
118. Chatila T., Geha R.S. Signal transduction by microbial superantigens via MHC class II molecules Immunol. Rev. 131 1993 43 59
119. Chatila T. Toxic shock syndrome toxin-1 induces inositol phospholipid turnover, protein kinase C translocation, and calcium mobilization in human T-cells J. Immunol. 140 1988 1250 1255
120. Scholl P.R. Role of protein tyrosine phosphorylation in monokine induction by the staphylococcal superantigen toxic shock syndrome toxin-1 J. Immunol. 148 1992 2237 2241
121. Trede N.S. Transcriptional activation of the human TNF-alpha promoter by superantigen in human monocytic cells: role of NF-κB. J. Immunol. 155 1995 902 908
122. + T-cells express perturbed AP-1 and NF-κB transcription factors Proc. Natl. Acad. Sci. USA 93 1996 979 984
123. Krakauer T. Induction of CC chemokines in human peripheral blood mononuclear cells by staphylococcal exotoxins and its prevention by pentoxifylline J. Leukoc. Biol. 66 1999 158 164
124. Krakauer T. Inhibition of toxic shock syndrome toxin-1 induced cytokine production and T-cell activation by interleukin-10, interleukin-4, and dexamethasone J. Infect. Dis. 172 1995 988 992
125. Carlsson R. Binding of staphylococcal enterotoxin A to accessory cells is a requirement for its ability to activate human T-cells J. Immunol. 140 1988 2484 2488
126. Trede N.S. Transcriptional activation of IL-1 beta and tumor necrosis factor-alpha genes by MHC class II ligands J. Immunol. 146 1991 2310 2315
127. Fischer H. Production of TNF-alpha and TNF-beta by staphylococcal enterotoxin A activated human T-cells J. Immunol. 144 1990 4663 4669
128. Lagoo A. IL-2, IL-4, and IFN-gamma gene expression versus secretion in superantigen-activated T-cells. Distinct requirement for costimulatory signals through adhesion molecules J. Immunol. 152 1994 1641 1652
129. Lando P.A. Regulation of superantigen-induced T-cell activation in the absence and the presence of MHC class II J. Immunol. 157 1996 2857 2863
130. Hewitt C. wMajor histocompatibility complex independent clonal T-cell anergy by direct interaction of Staphylococcus aureus enterotoxin B with the T-cell antigen receptor J. Exp. Med. 175 1996 1493 1499
131. Stohl W. Human T-cell-dependent B cell differentiation induced by staphylococcal superantigens J. Immunol. 153 1994 117 127
132. Mourad W. Engagement of major histocompatibility complex class II molecules by superantigen induces inflammatory cytokine gene expression in human rheumatoid fibroblast-like synoviocytes J. Exp. Med. 175 1992 613 616
133. Wooley P.H., Cingel B. Staphylococcal enterotoxin B increases the severity of type II collagen induced arthritis in mice Ann. Rheum. Dis. 54 1995 298 304